UCB (UCB)

Index:

BEL 20

  156.95
   
  • Change Today:
     -1.35
  • 52 Week High:  196.80
  • 52 Week Low:  126.50
  • Currency: Euro
  • Shares Issued: 190.00m
  • Volume: 10,610
  • Market Cap:  29,820m
  • Beta: 1.56

Latest ShareCast News

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

By Michele Maatouk

Date: Thursday 10 Oct 2019

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.

UCB ShareCast News

No recent information was found.

UCB Newspaper Links

GSK gets emerging markets boost with UCB deal 24-Jan-2009 Telegraph
UCB confident on drug go-ahead 21-Aug-2007 The Scotsman
Fellner shuffles Acambis board 08-Mar-2007 Telegraph
Deal speeds drugs sector consolidation 26-Sep-2006 The Herald

UCB Tips & Analysis

No recent information was found.

UCB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

UCB Market Data

Currency Euro
Share Price   156.95
Change Today   -1.35
% Change -0.85 %
52 Week High  196.80
52 Week Low  126.50
Volume 10,610
Shares Issued 190.00m
Market Cap  29,820m
Beta 1.56

What The Brokers Say

Strong Buy 6
Buy 9
Neutral 6
Sell 0
Strong Sell 0
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 28-May-2025

Time Volume / Share Price
10:37 6 @  157.00
10:37 68 @  157.00
10:37 71 @  157.00
10:37 35 @  157.00
10:37 6 @  157.00

Top of Page